<![CDATA[<body bgcolor="#FFFFFF" text="#000000">
MEDIA
60.96% revenue growth and 169.31% net profit growth for FY05
Receipt of First Milestone from Forest Laboratories Inc.
Collaboration of Glenmark Pharmaceuticals and Teijin Pharma Limited
INVESTORS
Audited Financial Results
Management Discussion and Analysis
Shareholding Patterns
</body>]]>